Outset Medical, Inc. Share-based Payment Arrangement, Expense
Outset Medical, Inc. (OM) reported Share-based Payment Arrangement, Expense of $2.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-06
- Outset Medical, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $2.70M, a 22.88% decline year-over-year.
- Outset Medical, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $3.45M, a 15.99% increase year-over-year.
- Outset Medical, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $4.06M, a 17.84% decline year-over-year.
- Outset Medical, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $5.08M, a 20.48% decline year-over-year.
- Outset Medical, Inc. share-based payment arrangement, expense for fiscal 2025 was $15.62M, a 46.80% decline from fiscal 2024.
- Outset Medical, Inc. share-based payment arrangement, expense for fiscal 2024 was $29.36M, a 24.02% decline from fiscal 2023.
- Outset Medical, Inc. share-based payment arrangement, expense for fiscal 2023 was $38.63M, a 42.02% increase from fiscal 2022.
- Outset Medical, Inc. share-based payment arrangement, expense for fiscal 2022 was $27.20M, a 55.94% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.70M 10-Q · filed 2026-08-06 | $6.15M 10-Q · filed 2026-08-06 | $10.21M derived: sum of 3 quarters · filed 2026-08-06 | $15.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.45M 10-Q · filed 2026-05-07 | $7.52M derived: sum of 2 quarters · filed 2026-05-07 | $12.60M derived: sum of 3 quarters · filed 2026-05-07 | $16.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $9.14M derived: sum of 2 quarters · filed 2026-02-13 | $12.64M derived: sum of 3 quarters · filed 2026-08-06 | $15.62M 10-K · filed 2026-02-13 |
| 2025-09-30 | $5.08M 10-Q · filed 2025-11-10 | $8.58M derived: sum of 2 quarters · filed 2026-08-06 | $11.55M 10-Q · filed 2025-11-10 | $16.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $3.50M 10-Q · filed 2026-08-06 | $6.47M 10-Q · filed 2026-08-06 | $11.42M derived: sum of 3 quarters · filed 2026-08-06 | $17.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.98M 10-Q · filed 2026-05-07 | $7.92M derived: sum of 2 quarters · filed 2026-05-07 | $14.31M derived: sum of 3 quarters · filed 2026-05-07 | $24.13M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $4.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $11.33M derived: sum of 2 quarters · filed 2026-02-13 | $21.15M derived: sum of 3 quarters · filed 2026-02-13 | $29.36M 10-K · filed 2026-02-13 |
| 2024-09-30 | $6.39M 10-Q · filed 2025-11-10 | $16.21M derived: sum of 2 quarters · filed 2025-11-10 | $24.41M 10-Q · filed 2025-11-10 | $33.51M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $9.82M 10-Q · filed 2025-08-07 | $18.02M 10-Q · filed 2025-08-07 | $27.12M derived: sum of 3 quarters · filed 2026-02-13 | $38.01M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $8.20M 10-Q · filed 2025-05-08 | $17.30M derived: sum of 2 quarters · filed 2026-02-13 | $28.19M derived: sum of 3 quarters · filed 2026-02-13 | $38.30M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $19.99M derived: sum of 2 quarters · filed 2026-02-13 | $30.10M derived: sum of 3 quarters · filed 2026-02-13 | $38.63M 10-K · filed 2026-02-13 |
| 2023-09-30 | $10.89M 10-Q · filed 2024-11-07 | $21.00M derived: sum of 2 quarters · filed 2024-11-07 | $29.54M 10-Q · filed 2024-11-07 | $36.89M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $10.11M 10-Q · filed 2024-08-08 | $18.64M 10-Q · filed 2024-08-08 | $26.00M derived: sum of 3 quarters · filed 2025-02-28 | $33.43M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $8.54M 10-Q · filed 2024-05-09 | $15.89M derived: sum of 2 quarters · filed 2025-02-28 | $23.32M derived: sum of 3 quarters · filed 2025-02-28 | $30.73M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $7.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $14.78M derived: sum of 2 quarters · filed 2025-02-28 | $22.20M derived: sum of 3 quarters · filed 2025-02-28 | $27.20M 10-K · filed 2025-02-28 |
| 2022-09-30 | $7.43M 10-Q · filed 2023-11-08 | $14.84M derived: sum of 2 quarters · filed 2023-11-08 | $19.85M 10-Q · filed 2023-11-08 | $24.64M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $7.41M 10-Q · filed 2023-08-03 | $12.42M 10-Q · filed 2023-08-03 | $17.21M derived: sum of 3 quarters · filed 2024-02-21 | $20.08M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $5.01M 10-Q · filed 2023-05-04 | $9.80M derived: sum of 2 quarters · filed 2024-02-21 | $12.66M derived: sum of 3 quarters · filed 2024-02-21 | $16.60M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $7.66M derived: sum of 2 quarters · filed 2024-02-21 | $11.59M derived: sum of 3 quarters · filed 2024-02-21 | $17.45M 10-K · filed 2024-02-21 |
| 2021-09-30 | $2.86M 10-Q · filed 2022-11-09 | $6.80M derived: sum of 2 quarters · filed 2022-11-09 | $12.65M 10-Q · filed 2022-11-09 | $18.92M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $3.94M 10-Q · filed 2022-08-02 | $9.79M 10-Q · filed 2022-08-02 | $16.06M derived: sum of 3 quarters · filed 2023-02-13 | $29.96M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | $5.85M 10-Q · filed 2022-05-05 | $12.12M derived: sum of 2 quarters · filed 2023-02-13 | $26.03M derived: sum of 3 quarters · filed 2023-02-13 | $26.71M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | $6.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $20.18M derived: sum of 2 quarters · filed 2023-02-13 | $20.86M derived: sum of 3 quarters · filed 2023-02-13 | $21.44M 10-K · filed 2023-02-13 |
| 2020-09-30 | $13.91M 10-Q · filed 2021-11-04 | $14.59M derived: sum of 2 quarters · filed 2021-11-04 | $15.17M 10-Q · filed 2021-11-04 | $15.42M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $683.00K 10-Q · filed 2021-08-06 | $1.26M 10-Q · filed 2021-08-06 | $1.51M derived: sum of 3 quarters · filed 2022-02-23 | $1.75M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $580.00K 10-Q · filed 2021-05-06 | $827.00K derived: sum of 2 quarters · filed 2022-02-23 | $1.06M derived: sum of 3 quarters · filed 2022-02-23 | |
| 2019-12-31 | $247.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $483.00K derived: sum of 2 quarters · filed 2022-02-23 | $883.00K 10-K · filed 2022-02-23 | |
| 2019-09-30 | $236.00K 10-Q · filed 2020-11-12 | $636.00K 10-Q · filed 2020-11-12 | ||
| 2018-12-31 | $788.00K 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |